Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A42387 | 34699206 | J Nat Prod | Hypocholesterolemic Efficacy of Secoisolariciresinol Diglucoside and Its Polymer in Rat. | 2021 | Details |
| A42388 | 34698580 | Crit Rev Food Sci Nutr | Effect of kombucha intake on the gut microbiota and obesity-related comorbidities: A systematic review. | 2021 | Details |
| A42389 | 34698347 | Clin Infect Dis | Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. | 2022 | Details |
| A42390 | 34697893 | J Dig Dis | Multidisciplinary participation: The key to a cure for non-alcoholic fatty liver disease. | 2021 | Details |
| A42391 | 34691404 | Clin Liver Dis (Hoboken) | Nonalcoholic Fatty Liver Disease: Indian Perspective. | 2021 | Details |
| A42392 | 34689140 | Horm Res Paediatr | Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion. | 2021 | Details |
| A42393 | 34678406 | J Hepatol | One not like the other: The weakness of the blood sugar-MAFLD analogy. | 2021 | Details |
| A42394 | 34675485 | Drug Des Devel Ther | Saroglitazar - A Potential Therapeutic Option in Treating NASH? [Letter]. | 2021 | Details |
| A42395 | 34675006 | Diabetes | Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication. | 2021 | Details |
| A42396 | 34674606 | Gut Microbes | Akkermansia muciniphila: is it the Holy Grail for ameliorating metabolic diseases? | 2022 | Details |
| A42397 | 34670048 | N Engl J Med | Nonalcoholic Steatohepatitis - Opportunities and Challenges. | 2021 | Details |
| A42398 | 34666783 | J Transl Med | Correction to: Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway. | 2021 | Details |
| A42399 | 34666202 | J Proteomics | Two untargeted metabolomics reveals yogurt-associated metabolic alterations in women with multiple metabolic disorders from a randomized controlled study. | 2021 | Details |
| A42400 | 34653824 | Clin Nutr | Reply-letter to the editor: Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg? | 2021 | Details |
| A42401 | 34634826 | Semin Thromb Hemost | Démonstration de Faisabilité: Nonalcoholic Fatty Liver Disease May Cause Thrombocytopenia. | 2021 | Details |
| A42402 | 34633856 | Annu Rev Nutr | Microbial Flavonoid Metabolism: A Cardiometabolic Disease Perspective. | 2021 | Details |
| A42403 | 34630116 | Front Pharmacol | An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism. | 2021 | Details |
| A42404 | 34629818 | World J Gastroenterol | Liver disease in the era of COVID-19: Is the worst yet to come? | 2021 | Details |
| A42405 | 34626045 | Liver Transpl | A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients. | 2021 | Details |
| A42406 | 34621322 | Evid Based Complement Alternat Med | YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats. | 2021 | Details |
| A42407 | 34618686 | J Clin Invest | Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance. | 2021 | Details |
| A42408 | 34617616 | Clin Endocrinol (Oxf) | Long-term health outcomes in young women with polycystic ovary syndrome: A narrative review. | 2021 | Details |
| A42409 | 34616249 | Case Rep Gastroenterol | Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy. | 2021 | Details |
| A42410 | 34616001 | Cell Death Differ | Ssu72-HNF4α signaling axis classify the transition from steatohepatitis to hepatocellular carcinoma. | 2021 | Details |
| A42411 | 34606755 | Am J Med Sci | Physical Activity, Inactivity and Sleep in Patients with Significant Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A42412 | 34603218 | Front Endocrinol (Lausanne) | Editorial: The Brain - Gut - Microbiome Network in Metabolic Regulation and Dysregulation. | 2021 | Details |
| A42413 | 34601829 | Hepatol Commun | Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis. | 2021 | Details |
| A42414 | 34600840 | J Clin Lipidol | Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome. | 2021 | Details |
| A42415 | 34599880 | Am J Pathol | METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice. | 2021 | Details |
| A42416 | 34593033 | Trials | Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial. | 2021 | Details |
| A42417 | 34592095 | Anal Chem | Correction to Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42418 | 34590125 | J Nutr | Diet and Liver Adiposity in Older Adults: The Multiethnic Cohort Adiposity Phenotype Study. | 2021 | Details |
| A42419 | 34587344 | Liver Int | One liver, two samples and two diagnoses-An example of how multiple samples by laparoscopically guided liver biopsy can be decisive. | 2021 | Details |
| A42420 | 34572393 | Biomedicines | Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease. | 2021 | Details |
| A42421 | 34572340 | Biomedicines | Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes. | 2021 | Details |
| A42422 | 34572325 | Biomedicines | Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations. | 2021 | Details |
| A42423 | 34564583 | Vet Sci | Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice. | 2021 | Details |
| A42424 | 34563920 | EBioMedicine | What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD). | 2021 | Details |
| A42425 | 34561782 | J Digit Imaging | Active Learning for Efficient Segmentation of Liver with Convolutional Neural Network-Corrected Labeling in Magnetic Resonance Imaging-Derived Proton Density Fat Fraction. | 2021 | Details |
| A42426 | 34561721 | Eur J Pediatr | Correction to: Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. | 2022 | Details |
| A42427 | 34555344 | Lancet Gastroenterol Hepatol | The challenge of cardiovascular prevention in NAFLD. | 2021 | Details |
| A42428 | 34550600 | J Cell Physiol | The molecular structure and role of LECT2 or CHM-II in arthritis, cancer, and other diseases. | 2021 | Details |
| A42429 | 34543866 | Clin Imaging | Reliability of performing ultrasound derived SWE and fat fraction in adult livers. | 2021 | Details |
| A42430 | 34542351 | Crit Rev Food Sci Nutr | Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity? | 2021 | Details |
| A42431 | 34541981 | Expert Opin Pharmacother | Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease. | 2021 | Details |
| A42432 | 34540892 | Front Mol Biosci | Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway. | 2021 | Details |
| A42433 | 34532001 | Food Sci Nutr | L-citrulline inhibits body weight gain and hepatic fat accumulation by improving lipid metabolism in a rat nonalcoholic fatty liver disease model. | 2021 | Details |
| A42434 | 34530064 | J Hepatol | NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver. | 2021 | Details |
| A42435 | 34528626 | J R Coll Physicians Edinb | The effect of hydroxychloroquine on non-alcoholic fatty liver disease among rheumatoid arthritis patients. | 2021 | Details |
| A42436 | 34520785 | J Hepatol | An elevated FIB-4 score predicts liver cancer development: A longitudinal analysis from 29,999 patients with NAFLD. | 2021 | Details |
| A42437 | 34520784 | J Hepatol | Reply to: "Multiple investigations for a very common disorder: Finding the right balance in NAFLD". | 2021 | Details |
| A42438 | 34519579 | Radiology | NASH Diagnosis Made Better but Maybe Not Yet Easier. | 2021 | Details |
| A42439 | 34519532 | mSystems | Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model. | 2021 | Details |
| A42440 | 34516292 | Annu Rev Pharmacol Toxicol | Synthetic Retinoids Beyond Cancer Therapy. | 2021 | Details |
| A42441 | 34511811 | J Clin Exp Hepatol | Lean Fatty Liver Disease: Through Thick and Thin. | 2021 | Details |
| A42442 | 34511550 | Nihon Shokakibyo Gakkai Zasshi | [Treatment for nonalcoholic steatohepatitis -current status and future prospects of pharmacotherapy]. | 2021 | Details |
| A42443 | 34511549 | Nihon Shokakibyo Gakkai Zasshi | [Follow-up of patients with NAFLD, based on systemic diseases -Look at the trees and see the forest]. | 2021 | Details |
| A42444 | 34511548 | Nihon Shokakibyo Gakkai Zasshi | [Pathology of NASH/NAFLD]. | 2021 | Details |
| A42445 | 34511547 | Nihon Shokakibyo Gakkai Zasshi | [From NAFLD to MAFLD]. | 2021 | Details |
| A42446 | 34509980 | Gut | Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed. | 2021 | Details |
| A42447 | 34509644 | Clin Gastroenterol Hepatol | Untangling the Influence of Sex Hormones on Nonalcoholic Fatty Liver Disease in Women. | 2021 | Details |
| A42448 | 34509395 | Dig Liver Dis | Genes and lifestyle: Which of the two is more relevant in driving NAFLD progression? | 2021 | Details |
| A42449 | 34509272 | Ann Hepatol | Simultaneous Metabolic and Alcohol-associated Fatty Liver Disease (SMAFLD) and Simultaneous Metabolic and Alcohol-associated Steatohepatitis (SMASH). | 2022 | Details |
| A42450 | 34509189 | Lancet Gastroenterol Hepatol | Integration of public health measures for NAFLD into India's national programme for NCDs. | 2021 | Details |
| A42451 | 34509188 | Lancet Gastroenterol Hepatol | The lottery of primary care for liver disease. | 2021 | Details |
| A42452 | 34503598 | J Dev Orig Health Dis | Metabolic programming in offspring of mice fed fructose during pregnancy and lactation. | 2021 | Details |
| A42453 | 34497430 | World J Gastroenterol | Malnutrition and liver disease in a developing country. | 2021 | Details |
| A42455 | 34496266 | J Ethnopharmacol | Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice. | 2021 | Details |
| A42456 | 34486131 | Alcohol Clin Exp Res | Trehalose activates hepatic transcription factor EB (TFEB) but fails to ameliorate alcohol-impaired TFEB and liver injury in mice. | 2021 | Details |
| A42457 | 34484704 | Clin Liver Dis (Hoboken) | Review of Clinical Guidelines in the Diagnosis of Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42458 | 34484702 | Clin Liver Dis (Hoboken) | Transition of Care Model for Pediatric Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A42459 | 34484330 | J Oncol | ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. | 2021 | Details |
| A42460 | 34476661 | Dig Dis Sci | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. | 2021 | Details |
| A42461 | 34475732 | Ann Gastroenterol | Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. | 2021 | Details |
| A42462 | 34474907 | Am J Cardiol | Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication. | 2021 | Details |
| A42463 | 34464658 | J Hepatol | Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change. | 2021 | Details |
| A42464 | 34461302 | Clin Gastroenterol Hepatol | Perinatal Risk Factors for Pediatric Nonalcoholic Fatty Liver Disease: Impact of Inborn Errors of Metabolism. | 2021 | Details |
| A42465 | 34461208 | J Hepatol | Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease - implications for the clinical utility of the EASL NIT guideline. | 2021 | Details |
| A42466 | 34461065 | Cell Mol Gastroenterol Hepatol | Crossing the Rubicon: Adipose Tissue Autophagy Breaks Out NAFLD. | 2021 | Details |
| A42467 | 34458710 | Surg Open Sci | In vivo diffuse reflectance spectroscopic analysis of fatty liver with inflammation in mice. | 2021 | Details |
| A42468 | 34455682 | Liver Int | PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system. | 2021 | Details |
| A42469 | 34455076 | Pharmacol Res | The pivotal role of Nrf2 activators in adipocyte biology. | 2021 | Details |
| A42470 | 34449134 | Obesity (Silver Spring) | Salmon peptides limit obesity-associated metabolic disorders by modulating a gut-liver axis in vitamin D-deficient mice. | 2021 | Details |
| A42471 | 34447810 | World J Clin Cases | Nonalcoholic fatty pancreas disease: An emerging clinical challenge. | 2021 | Details |
| A42472 | 34447672 | J Clin Transl Hepatol | Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken? | 2021 | Details |
| A42473 | 34445250 | Int J Mol Sci | A Novel Oxygen Carrier (M101) Attenuates Ischemia-Reperfusion Injuries during Static Cold Storage in Steatotic Livers. | 2021 | Details |
| A42474 | 34441377 | Diagnostics (Basel) | Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index. | 2021 | Details |
| A42475 | 34440714 | Cells | Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. | 2021 | Details |
| A42476 | 34439969 | Biology (Basel) | Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice. | 2021 | Details |
| A42477 | 34436472 | Metabolites | The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions. | 2021 | Details |
| A42478 | 34432677 | Eur J Gastroenterol Hepatol | Differences between sporadic hyperplastic gastric polyps and portal hypertensive gastric polyps: a review. | 2022 | Details |
| A42479 | 34427594 | JAMA | Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. | 2021 | Details |
| A42480 | 34425095 | Gastroenterology | Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity. | 2021 | Details |
| A42481 | 34422393 | J Gastrointest Oncol | A discussion of the gut microbiome's development, determinants, and dysbiosis in cancers of the esophagus and stomach. | 2021 | Details |
| A42482 | 34416820 | Annu Rev Pathol | Long Noncoding RNAs and Human Liver Disease. | 2021 | Details |
| A42483 | 34414117 | Liver Cancer | Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma? | 2021 | Details |
| A42484 | 34409847 | Antioxid Redox Signal | Insufficient S-Sulfhydration of Methylenetetrahydrofolate Reductase Contributes to the Progress of Hyperhomocysteinemia. | 2021 | Details |
| A42485 | 34406370 | Eur Heart J | The heart of FOIE GRAS and mtFOIE GRAS: fundamental and clinical investigation for training and innovation in non-alcoholic fatty liver disease. | 2022 | Details |
| A42486 | 34402808 | J Pediatr Gastroenterol Nutr | Identifying the Genetics Underlying Nonalcoholic Fatty Liver Disease: A Quest That is Far From Over. | 2021 | Details |
| A42487 | 34402268 | Zhongguo Zhong Yao Za Zhi | [Efficacy and mechanism of new resource medicinal materia Moringa oleifera leaves against hyperlipidemia]. | 2021 | Details |